Skip to content

Methodological study of auxiliary diagnosis and screening of hepatobiliary malignancies based on mass spectrometry analysis

Methodological study of auxiliary diagnosis and screening of hepatobiliary malignancies based on mass spectrometry analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104071
Enrollment
Unknown
Registered
2025-06-10
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatobiliary Malignant Tumors

Interventions

Hepatobiliary malignant tumor group:None
Benign disease group:None

Sponsors

Shanghai East Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age over 18 years old; 2. Accept liver malignant tumor resection surgery or biopsy; 3. Patients who can be confirmed to have benign diseases and seek medical treatment; 4. The laboratory department of the hospital retains the remaining serum/plasma of the corresponding patient after routine clinical testing.

Exclusion criteria

Exclusion criteria: 1. Age under 18 years old; 2. Patients with liver and gallbladder malignant tumors who lack clinical pathological diagnosis results; 3. Patients who cannot determine whether they have other malignant tumors; 4. The laboratory department of the center is unable to locate the remaining serum/plasma after routine clinical testing corresponding to the patient.

Design outcomes

Primary

MeasureTime frame
Abundance of various metabolites in serum/plasma;

Countries

China

Contacts

Public ContactLi Yesheng

Shanghai East Hospital

leeeyesheng@163.com+86 181 2115 3053

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026